The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994–2003—A global pharmaceutical data analysis
- 30 September 2010
- journal article
- Published by Elsevier in Health Policy
- Vol. 97 (1) , 71-78
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Global Market For ADHD MedicationsHealth Affairs, 2007
- Prescription-Drug PricesNew England Journal of Medicine, 2004
- Are psychostimulant drugs being used appropriately to treat child and adolescent disorders?The British Journal of Psychiatry, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence‐based reports to prescribersPharmacoepidemiology and Drug Safety, 2002
- Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity DisorderPediatrics, 2001
- The U.S. Pharmaceutical Industry: Why Major Growth In Times Of Cost Containment?Health Affairs, 2001
- Explaining Drug Spending Trends: Does Perception Match Reality?Health Affairs, 2000
- THE DIAGNOSIS OF CHILDHOOD HYPERACTIVITY A U.S.‐U. K. CROSS‐NATIONAL STUDY OF DSM—III and ICD‐9Journal of Child Psychology and Psychiatry, 1988
- Household Expenditure Patterns in Tianjin,The China Quarterly, 1987